Delivery Order SPE2DB24D2100-SPE2DB25FBFRM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Lacosamide 10 mg/mL solution in 200 mL quantities, with a ceiling value of $1,351.98 and an ultimate completion date of August 22, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Lacosamide 10 mg/ml Solution in a 200ml quantity, with a ceiling value of $2,681.84 and an ultimate completion date of August 20, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, the company's headquarters...
- AmerisourceBergen Drug Corp was awarded a delivery order on August 12, 2025, by the Defense Logistics Agency's Medical Supply Chain for the supply of Lacosamide 10 mg/ml solution in a 200 ml quantity, with a contract ceiling value of $1,051.54. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for ultimate completion by August 13, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lacosamide 10 mg/ml Solution 200ml, with a ceiling value of $1,002.66 under a firm fixed price contract structure. This competitively awarded delivery order, issued on November 3, 2025, with an ultimate completion date of November 4, 2025, represents a continuation of the vendor's ongoing pharmaceutical supply relationship with the federal government. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lacosamide 10 mg/ml solution in a 200ml quantity, with a contract ceiling value of $3,155.52. This award was made on November 3, 2025, with an ultimate completion date of November 4, 2025, under a firm fixed price delivery order with no set-aside designation. The contract represents a competitive award for pharmaceutical procurement to support federal medical supply needs, with performance...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,638.72 to supply Lacosamide 10 mg/mL solution in a 200 mL quantity. This competitively awarded, firm fixed-price delivery order, issued on November 18, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX, valued at $999,999,999.00 through December 2026). The place of performance is listed as Conshohocken,...
- The Defense Logistics Agency awarded a $2,280.86 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Lacosamide 10 mg/ml Solution in a 200 ml volume. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 19, 2025. Lacosamide is an anticonvulsant medication used primarily for the treatment of partial-onset seizures. The product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency Troop Support Medical awarded a $176,940 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 milliliters of the pharmaceutical product lacosamide 10 mg/ml solution. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 31, 2023 through August 1, 2023. This delivery order was issued against an existing indefinite-delivery/indefinite-quantity contract vehicle held...
- The U.S. Defense Department's Medical Supply Chain awarded a $1,433.01 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Lacosamide 50 mg/5 mL unit dose vials. This competitively awarded, non-set-aside contract is scheduled for completion by September 18, 2025, with performance to be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child action under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Lacosamide 200 mg/20 mL vials valued at $2,509.57. This is a firm fixed-price delivery order with an ultimate completion date of September 25, 2025, and represents no set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBFRMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Lacosamide 10 mg/ml Solution in a 200 ml volume at a ceiling value of $1,022.72. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at approximately $1 billion through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. Lacosamide is an anticonvulsant medication utilized in neurological treatment protocols. This delivery order demonstrates the vendor's continued capability to fulfill federal pharmaceutical requirements through competitive procurement channels, consistent with its extensive portfolio of delivery orders for medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/6/25 |